Figure 5
From: Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland
Influence of iron status on Hb and EPO dose. The iron status was divided into 3 categories, according to ferritin and TSAT (as defined in the text). Values at baseline, month 6 and 12 are shown. * Significant difference observed between patients with "adequate iron status" and "absolute iron deficiency" at baseline. ** Significant difference observed between patients with "functional iron deficiency" and "adequate iron stores" at month 6 (p = 0.0004 for Hb and p = 0.008 for the EPO dose) and month 12 (p = 0.03 for Hb, difference not significant for EPO dose).